Previous 10 | Next 10 |
Penumbra Inc. (PEN) Q4 2018 Results Earnings Conference Call February 26, 2019 04:30 PM ET Company Participants Dan Wilson - Head of Business Development Adam Elsesser - Chairman and Chief Executive Officer Sridhar Kosaraju - Chief Financial Officer Conference Call Participant...
Penumbra (NYSE: PEN ): Q4 Non-GAAP EPS of $0.13 misses by $0.02 ; GAAP EPS of $0.18 beats by $0.03 . More news on: Penumbra, Earnings news and commentary, Healthcare stocks news, Read more ...
ALAMEDA, Calif. , Feb. 26, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the fourth quarter and full year ended December 31, 2018 . Financial Highlights: Revenue of...
AAXN , ACAD , AKCA , ARNA , AXGN , BGS , BNFT , CERS , CLGX , CPE , CSGP , CW , DRQ , DVAX , ELF , ENPH , EOG , EVH , FOXF , FRPT , FTR , GWPH , HEI , HPR , HURN , HY , ICFI , IMAX , IMMR , INGN , INN , INSP , JAZZ , JBGS , MASI , MED , MELI , MGRC , M...
Even though Stryker ( SYK ) had built an exceptional growth record, the shares had nevertheless underperformed going into the fourth quarter. I attribute that underperformance to worries about the company’s ability to maintain that impressive growth rate, with some investors choosing ...
ALAMEDA, Calif. , Jan. 30, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2018 after market close on Tuesday, February 26, 2019 at 4:30 PM Eastern Time. A ...
ALAMEDA, Calif. , Jan. 18, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that two new Board members were appointed to its Board of Directors (the "Board") on January 17, 2019 . Ms. Janet Leeds was appointed to the Board as a Class I director, effective immediatel...
NEW YORK, Jan. 11, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Akamai Technologies, Inc. (NASDAQ:AKAM), Dynex Capital, Inc. (NYSE:DX), M...
ALAMEDA, Calif. , Dec. 20, 2018 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 37 th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 8 , 2019. A webcast of th...
I loved just about everything about Penumbra ( PEN ) except the price/upside when I last wrote about this fast-growing neurovascular med-tech company. Since then, the company has continued to sail past sell-side expectations, but the market has gotten more risk-averse and worries have crop...
News, Short Squeeze, Breakout and More Instantly...
2024-07-13 17:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-03 18:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024 PR Newswire ALAMEDA, Calif. , July 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial resu...